Conclusion
CAR, an inflammatory marker in patients with STEMI, is known to
influence the rates of mortality and morbidity. However, the
relationship between CAR and IRA patency has not been investigated. This
is the first study to reveal a significant relationship between the IRA
patency and CAR before p-PCI in STEMI. The C-reactive protein/albumin
ratio is an easy and reliable indicator that can be used to determine
IRA patency in patients with STEMI.